| Investigator |
Title |
Sponsor |
ID |
Dates |
Amount |
| Andrew D Hershey, MDPHD |
A single arm, open label, multicenter study of the safety and efficacy of Nerivio™ for the acute treatment of migraine in adolescents |
Theranica Bio-electronics |
Theranica TCH004 |
09/01/2019 - 08/31/2024 |
$125,552 |
| Charles V Vorhees, PHD |
Annual Meeting of the Developmental Neurotoxicology Society |
Food and Drug Administration (Food and Drug Administration) |
R13FD004852 |
07/01/2019 - 07/31/2020 |
$5,500 |
| Christina Gross, PHD |
MicroRNA-mediated silencing of the Kv4.2 complex in epil |
National Institutes of Health (NIH) |
R01NS092705 |
01/01/2020 - 12/31/2020 |
$307,125 |
| Christina Gross, PHD |
Functional analysis of the microRNA-induced silencing complex in epilepsy |
National Institutes of Health (NIH) |
R01NS107453 |
12/01/2019 - 11/30/2020 |
$347,813 |
| Cuixia Tian, MD |
MDA Care Center Grant |
Muscular Dystrophy Association |
492633 |
01/01/2020 - 06/30/2020 |
$25,000 |
| Cuixia Tian, MD |
MDA Neuromuscular Observational Research (MOVR) Data Hub |
Muscular Dystrophy Association |
Muscular Dystrophy A |
06/26/2019 - 12/31/2020 |
$16,750 |
| Cuixia Tian, MD |
PPMD Grant Award 2019 for Cincinnati Children's Certified Duchenne Care Center |
Parent Project Muscular Dystrophy |
Tian_PPMD |
01/01/2019 - 12/31/2020 |
$5,000 |
| Darcy Krueger, MD |
Developmental Synaptopathies Associated with TSC, PTEN and SHANK3 Mutations |
Children's Hospital Boston (National Institutes of Health) |
GENFD0001761815 |
07/01/2019 - 06/30/2020 |
$75,982 |
| Darcy Krueger, MD |
Developmental Synaptopathies Associated with TSC, PTEN and SHANK3 Mutations |
Children's Hospital Boston (National Institutes of Health) |
81199.CCHMC.01.PTEN |
09/20/2019 - 07/31/2020 |
$52,947 |
| Darcy Krueger, MD |
TSC Natural History Database Project |
Tuberous Sclerosis Alliance |
2013DB18Y3 |
05/01/2016 - 12/31/2020 |
$18,450 |
| Darcy Krueger, MD |
TSC Biosample Repository Contract |
Tuberous Sclerosis Alliance |
2016BSR18 |
12/01/2016 - 12/31/2020 |
$10,795 |
| Darcy Krueger, MD |
Stopping TSC Onset and Progression 2 (STOP-2): Epilepsy Prevention in TSC Infants |
Tuberous Sclerosis Alliance |
2019-CRN-02 |
12/01/2019 - 11/30/2020 |
$200,000 |
| Darcy Krueger, MD |
Preventing Epilepsy Using Vigabatrin in Infants with Tub |
University of Alabama-Birmingham (National Institutes of Health) |
000510297-001 |
06/01/2019 - 05/31/2020 |
$91,071 |
| Darcy Krueger, MD |
Preventing Epilepsy using Vigabatrin in Infants with Tuberous Sclerosis Complex - Capitation PortionStart Date is 6/1/2019. |
University of Alabama-Birmingham (National Institutes of Health) |
000510297 |
07/01/2019 - 06/30/2020 |
$107,341 |
| Darren Kadis, PHD |
MEG Connectivity-Based Mapping of Critical Language Sites in Children Undergoing Epilepsy Surgery |
National Institutes of Health (NIH) |
1R21NS106631-01A1 |
09/01/2019 - 08/31/2020 |
$197,204 |
| Donald L Gilbert, MD |
A Multicenter, Placebo-Controlled, Double-Blind, Randomized, Parallel-Group, Phase 2b Study to Evaluate the Efficacy and Safety of Ecopipam Tablets in Children and Adolescent Subjects with Tourette’s Syndrome |
Emalex Biosciences, Inc |
CTA Emalex Bioscienc |
10/18/2019 - 10/17/2024 |
$51,521 |
| Donald L Gilbert, MD |
GABAergic Sensorimotor Dysfunction in Tourette Syndrome |
Kennedy Krieger Research Institute (National Institutes of Health) |
113091-0319 |
04/01/2019 - 03/31/2020 |
$189,960 |
| Donald L Gilbert, MD |
4/7-Collaborative genomic studies of Tourette Disorder |
National Institutes of Health (NIH) |
1R01MH115962-01 |
04/01/2020 - 03/31/2021 |
$119,250 |
| Jing Xiang, MD-PHD |
Neuromagnetic High Frequency Oscillations to Guide Epilepsy Surgery |
National Institutes of Health (NIH) |
R21NS104459 |
08/01/2019 - 07/31/2020 |
$192,691 |
| John Michael Taylor |
The Vascular effects of Infection in Pediatric Stroke (VIPS II) Study |
The Univ of California, San Francisco (National Institutes of Health) |
11258sc |
07/01/2019 - 06/30/2020 |
$6,042 |
| John Michael Taylor |
Perinatal Arterial Stroke: A Multi-site RCT of Intensive Infant Rehabilitation (I-ACQUIRE) "Study" |
University of Cincinnati (National Institutes of Health) |
011961-136901 |
09/01/2019 - 08/31/2022 |
$68,165 |
| Lubov Timchenko, PHD |
GSK3 beta study in patients with Myotonic Dystrophy 1 |
National Institutes of Health (NIH) |
R01AR073379 |
01/01/2020 - 12/31/2020 |
$446,321 |
| Lubov Timchenko, PHD |
CNS in congenital DM1: pathogenesis and therapeutic opportunities |
National Institutes of Health (NIH) |
R01NS115662 |
02/01/2020 - 01/31/2021 |
$358,917 |
| Matthew R Skelton, PHD |
Identifying critical periods for creatine in brain development |
Association for Creatine Deficiencies |
CARE001 |
08/01/2019 - 07/31/2020 |
$5,000 |
| Matthew R Skelton, PHD |
Using a ketogenic diet to treat creatine transporter deficiency |
National Institutes of Health (NIH) |
1R21NS111217-01 |
08/01/2019 - 07/31/2021 |
$437,250 |
| Shannon Michelle Standridge DO-MPH |
A Randomized, Double-Blind, Placebo-Controlled Study of Oral Trofinetide Versus Placebo in Female Children, Adolescents and Adults with Rett Syndrome. |
Acadia Pharmaceuticals |
ACP-2566-003 |
01/15/2020 - 01/14/2025 |
$18,123 |
| Tracy A Glauser, MD |
Instrumenting the Delivery System for a Genomics Research Information Commons |
Children's Hospital Boston (National Institutes of Health) |
GENFD0001706578 |
07/01/2019 - 06/30/2020 |
$278,250 |
| Tracy A Glauser, MD |
Cincinnati Neuroscience Clinical Trials Research Center (CinciNEXT) |
University of Cincinnati (National Institutes of Health) |
CinciNEXT Renewal |
07/01/2019 - 06/30/2020 |
$155,060 |
| Current Year Direct |
$3,913,080 |
